Akero Therapeutics, Inc. reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
South San Francisco, CA
SEC filing record 1 source field available
Fiscal year end
31 December
Akero Therapeutics, Inc. has filed 734 SEC EDGAR filings since 18 Dec 2018

SEC filing history

Showing 101-125 of 734 matching filings.

Per page
25
Current page
5
4

4

Filing date
12 Jun 2025
Reporting date
10 Jun 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
12 Jun 2025
Reporting date
10 Jun 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
09 Jun 2025
Reporting date
05 Jun 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
05 Jun 2025
Reporting date
03 Jun 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
05 Jun 2025
Reporting date
03 Jun 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
05 Jun 2025
Reporting date
03 Jun 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
05 Jun 2025
Reporting date
03 Jun 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
05 Jun 2025
Reporting date
03 Jun 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
05 Jun 2025
Reporting date
03 Jun 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
05 Jun 2025
Reporting date
03 Jun 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
04 Jun 2025
Reporting date
02 Jun 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
23 May 2025
Reporting date
22 May 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
144 File 001-38944

144 filing

Filing date
22 May 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
19 May 2025
Reporting date
15 May 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
144 File 001-38944

144 filing

Filing date
15 May 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SCHEDULE 13G/A File 005-91047

SCHEDULE 13G/A filing

Filing date
15 May 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SCHEDULE 13G/A File 005-91047

SCHEDULE 13G/A filing

Filing date
14 May 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
13 May 2025
Reporting date
12 May 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
144 File 001-38944

144 filing

Filing date
12 May 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SCHEDULE 13G/A File 005-91047

SCHEDULE 13G/A filing

Filing date
12 May 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
09 May 2025
Reporting date
07 May 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
08 May 2025
Reporting date
06 May 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .